Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPARα

Autor: Karwad, M.A., Couch, D.G., Wright, K.L., Tufarelli, C., Larvin, M., Lund, J., O'Sullivan, S.E.

Publikováno v: In Biochemical Pharmacology October 2019 168:465-472

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

Autor: Meyer, T., Caplin, M.E., Palmer, D.H., Valle, J.W., Larvin, M., Waters, J.S., Coxon, F., Borbath, I., Peeters, M., Nagano, E., Kato, H.

Publikováno v: In European Journal of Cancer 2010 46(3):526-533

Abstracts from the twenty-third meeting of the pancreatic society of Great Britain and Ireland at the Village Hotel, Leeds, UK

Autor: Johnson, C., Ammori, BJ, Davides, D., Vezakis, A., Larvin, M., McMahon, KJ, Powell, JJ, Hill, G., Storey, S., Murchison, J., Fearon, K., Ross, J., Siriwardena, AK, Pearce, NW, Smithies, A., Sargen, K., Demaine, A., Kingsnorth, A., Becker, KL, Kite, P., Barclay, GR, Snider, RH, Nylen, ES, White, JC, Martin, IG, McMahon, MJ, Raraty, MGT, Ward, JB, Vaillant, C., Neoptolemos, JP, Sutton, R., Petersen, OH, Creighton, J., Lyall, R., Wilson, D., Curtis, A., Charnley, R., Howes, N., Rutherford, S., McRonald, F., Ellis, I., Whitcomb, D., Mountford, R., Manu, M., Bramhall, SR, Gur, U., Gunson, BK, Le Cornu, KJ, Mayer, AD, Mirza, DF, McMaster, P., Buckets, JAC, King, LJ, Bell, JRG, Healy, J., Amin, Z., Predolac, D., Wotherspoon, A., Thompson, J., Norton, SA, Alderson, D., Kawesha, A., Ghaneh, P., Evans, JD, Campbell, Dawiskiba, S., Lemoine, NR, Andrén-Sandberg, A., Humphreys, M., Greenhalf, W., Stoner, EA, Piotrowicz, AJK, Evans, DF, Ainley, CC, White, SA, Pollard, C., Burden, AC, Clayton, HA, Davies, JE, Swift, SM, Hales, CN, Dennison, AR, London, NJM, Sutton, CD, White, S., Berry, DP, Chillistone, D., Rees, Y., Ammann, R., Heitz, Ph, Klöppel, G., Bimmler, Daniel, Graf, Rolf, Frick, Thomas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______805::2ca01ae58b15c25e22dbc431e956c733
http://doc.rero.ch/record/317940/files/12029_2008_Article_BF02925972.pdf

Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability

Autor: Alhamoruni, A, Wright, KL, Larvin, M, O'Sullivan, SE

Activation of cannabinoid receptors decreases emesis, inflammation, gastric acid secretion and intestinal motility. The ability to modulate intestinal permeability in inflammation may be important in therapy aimed at maintaining epithelial barrier in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::60265fe3264566e7c6af771fe74b5c7c
https://europepmc.org/articles/PMC3423254/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.